Tyrosine Kinase Inhibitors Market to Surpass USD 21.6 Billion by 2033 on Targeted Therapy Boom- (SRI)

London, UK - January 2026 | Strategic Revenue Insights Inc. The Tyrosine Kinase Inhibitors Market is witnessing a transformative growth phase as precision medicine reshapes global therapeutic strategies. Valued at USD 10.50 billion in 2024, the marke...